MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2013 before the NASDAQ Market opens on Wednesday, May 8, 2013. The company will conduct a conference call and an audio webcast at 8:30am EDT the same day.
Date: May 8, 2013
Time: 8:30 AM EDTListen via Internet: http://ir.vivus.com/ U.S. Toll-free: 877-359-2916 Outside U.S.: (+) 224-357-2386 A webcast replay will be available on the VIVUS website for 30 days. About VIVUS VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com . Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "estimate," "expect", "forecast," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc. Timothy E. Morris Chief Financial Officer email@example.com Dana B. Shinbaum firstname.lastname@example.org Investor Relations: The Trout Group Brian Korb email@example.com 646-378-2923 Morrow & Co., LLC Joseph J. Mills firstname.lastname@example.org 203-658-9423 Media Relations: GolinHarris Ashley Buford email@example.com (212) 373-6045 Joele Frank, Wilkinson Brimmer Katcher Matthew Sherman | Jennifer Beugelmans firstname.lastname@example.org | email@example.com 212-235-2665 | 212-895-8692
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts